- Research works
- 20 ▲ 18% vs 2018-21
- Citations
- 269 13.1 per fractional work
- Top-10% rate
- 11.6% all institutions 10.0%
- Open access
- 42% world 40%
- International
- 4% world 18%
Not ranked overall: Apexigen (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Apexigen (United States) work in?
In all years, 42% of research at Apexigen (United States) is in Life Sciences, 36% in Health Sciences. Its largest fields are Medicine (36%), Immunology and Microbiology (34%), Biochemistry, Genetics and Molecular Biology (9%). It does 1.9× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 13 fields, with their numbers
- Life Sciences942.3%
- Health Sciences736.4%
- Medicine736.4%
- Physical Sciences313.2%
- Chemistry13.3%
- Computer Science13.3%
- Engineering02.4%
- Materials Science01.6%
- Mathematics01.6%
- Physics and Astronomy01.0%
- Social Sciences28.1%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 13.3×. Every wedge is a field page.
All 8 fields, with their numbers
- Immunology and Microbiology13.33×1 works
- Mathematics3.43×0 works
- Biochemistry, Genetics and Molecular Biology3.21×1 works
- Arts and Humanities2.79×1 works
- Medicine2.46×4 works
- Computer Science0.52×0 works
- Social Sciences0.32×0 works
- Engineering0.13×0 works
Who are the top researchers at Apexigen (United States)?
Ranked on the quality score, Erin L. Filbert and Xiaodong Yang lead among researchers whose main affiliation is Apexigen (United States).
- 1
Erin L. Filbert
United States · #1,142,275 worldwide 702 citations · 63 works
- 2
Xiaodong Yang
United States · #1,700,319 worldwide 452 citations · 41 works
Which keywords describe research at Apexigen (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunity, Antigen Presentation, Dendritic Cells, Glycosylation, Immunotherapy, Tumor Microenvironment and Monoclonal Antibodies.
- Chimeric Antigen Receptor
- Macrophage
- Lymphoma
- Cancer
- Inflammation
- PD-1 and PD-L1
- Monoclonal Antibodies
- Immunotherapy
- Dendritic Cells
- Immunity
- Cancer Immunotherapy
- Antigen Presentation
- Glycosylation
- Tumor Microenvironment
- Immune Checkpoint Blockade
- Fc Receptors
- Therapeutic Antibodies
- Tumor Regression
- Activation
- CAR T Cells
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 20 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 20 words, with their numbers
- Cancer Immunotherapy6▲ 215×3 topics
- Immunity6▲ 81×2 topics
- Antigen Presentation4▲ 213×1 topic
- Dendritic Cells4▲ 185×1 topic
- Glycosylation2▲ 44×2 topics
- Immunotherapy2▲ 15×8 topics
- Tumor Microenvironment2▲ 26×2 topics
- Monoclonal Antibodies2▲ 62×2 topics
- Immune Checkpoint Blockade2▲ 147×1 topic
- PD-1 and PD-L12▲ 147×1 topic
- Fc Receptors2▲ 81×1 topic
- Inflammation2▲ 3.4×4 topics
- Therapeutic Antibodies2▲ 63×1 topic
- Cancer2▲ 5.4×4 topics
- Tumor Regression2▲ 85×2 topics
- Lymphoma1▲ 45×2 topics
- Activation1▲ 174×1 topic
- Macrophage1▲ 108×1 topic
- CAR T Cells1▲ 129×1 topic
- Chimeric Antigen Receptor1▲ 129×1 topic
Which research topics does Apexigen (United States) publish most on?
By volume in 2022-now: Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Immunotherapy and Immune Responses and Libraries and Information Services.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 2 CAR-T cell therapy research Oncology 1 works
- 3 Immunotherapy and Immune Responses Immunology 1 works
- 4 Libraries and Information Services Museology 0 works
- 5 Mathematical Biology Tumor Growth Modeling and Simulation 0 works
- 6 Arts, Culture, and Music Studies Cultural Studies 0 works
- 7 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
- 8 Advanced Biosensing Techniques and Applications Molecular Biology 0 works
- 9 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
- 10 Museums and Cultural Heritage Museology 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Apexigen (United States)'s research output changed?
Output in 2022-2025 was 18% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Apexigen (United States) as a percentage of every work published that year, 0.0000056% in 2024.
Fractional works of Apexigen (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in San Carlos
- Natera (United States)
- Protein Metrics (United States)
- TiVo (United States)
- Go2 for Lung Cancer
- Natus (United States)
- Cellerant Therapeutics (United States)
- Rosa (United States)
- Allakos (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Apexigen (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.